Nanomedicine: Anticancer Platelet‐Mimicking Nanovehicles (Adv. Mater. 44/2015)

Progress of cell membrane-derived biomimetic nanovesicles for cancer phototherapy

“…145 Additionally, platelets overexpress P-selectin, enabling platelets to clump together on tumor cells by binding directly to the elevated CD44 receptors on the surface of cancer cells. 136,146 Platelets, which have a long lifespan in the circulation, the ability to adhere to cancer cells, and respond to vascular damage, produce platelet exosomes. 147 Regarding internalizing tumor cells as nanoparticles, platelet exosomes outperform metrocytes.…”

Cell membrane-coated biomimetic nanomedicines: productive cancer theranostic tools

“…52 Polyacrylamide is also used in the construction of core nanogels of CNs for DOX, and is a synthetic hydrophilic polymer. 53 According to Bigaj-Jozefowska et al (2022) a significant subcategory of nano-sized drug carriers is the polymeric nanoparticle (PNP) family. Polymeric materials' excellent biocompatibility, biodegradability, and ability for fine-tuning of characteristics including form, size, and surface potential, are among its beneficial aspects for anticancer therapies.…”

Recent Advances in Nanotechnology for Breast Cancer Therapy

“…Compared with other groups, the melanin@RBC-M showed higher tumor accumulation and PTT e±cacy. Hu et al 51 reported that the platelet membrane camou°age core-shell nanocarrier structure (PM-NV) can be used to target tumor sites and speci¯cally release extracellular activator proteins and intracellular small molecule drugs. The results indicated that the system has the advantages of serum stability, speci¯c targeting and protein release on the tumor cell membrane (such as cetuximab and trastuzumab).…”